Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting about 1 in 100,000 people, according to the U.S. Centers for Disease Control and Prevention. While GBS is more common in men and ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Although Guillain-Barré syndrome (GBS) may rarely follow a recent infection with SARS-CoV-2, a ...

Dear Dr. Roach: You have written about immunocompromised people before, but what about those of us who have immune systems that overreact instead of underperform, such as with Guillain-Barre syndrome?

(By: Dr Daanish Chhapra, Consultant Neurology, Holy Family Hospital Bandra Mumbai) Guillain-Barré Syndrome (GBS) is a rare but serious autoimmune disorder. It leads to muscle weakness, numbness, and, ...

SHREVEPORT, La. - In 2011, Shane Sumlin's life changed overnight after being diagnosed with a rare neurological disorder called Guillain-Barre syndrome (GBS). It causes the body to attack its own ...

In a recent study published in Eurosurveillance, researchers investigated whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines induced Guillain-Barré syndrome (GBS). Study: ...

MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained benefit at ...